Multipurpose prevention technologies: Biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies

Infectious Diseases in Obstetrics and Gynecology

Volumn 2011, Issue , 2011, Pages

  Thurman, Andrea Ries ^a   Clark, Meredith R ^a   Doncel, Gustavo F ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; C31G; CARBOPOL 974P; CARRAGEENAN; CELLULOSE SULFATE; DAPIVIRINE; DERMASEPTIN; LEVONORGESTREL; LUBRICATING AGENT; MAGAININ DERIVATIVE; MICROBICIDE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; NONOXINOL 9; PRO 2000; SAVVY; TENOFOVIR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHLAMYDIA TRACHOMATIS; CONDOM; CONTRACEPTIVE DEVICE; DRUG DELIVERY SYSTEM; FOOD AND DRUG ADMINISTRATION; GENITAL TRACT INFECTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; INFECTION PREVENTION; NEISSERIA GONORRHOEAE; PANDEMIC; PH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEXUALLY TRANSMITTED DISEASE; TECHNOLOGY; TRICHOMONAS VAGINALIS; UNPLANNED PREGNANCY; UTERINE CERVIX CAP; VAGINITIS; CONTRACEPTION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; PREGNANCY; PREGNANCY COMPLICATION;

CONTRACEPTION; FEMALE; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY, UNPLANNED;

EID: 80053489212     PISSN: 10647449     EISSN: 10980997     Source Type: Journal    
DOI: 10.1155/2011/429403     Document Type: Review

References (106)

1. Stone A. B., HIV topical microbicides: the current development strategy is fully justified American Journal of Public Health 2004 94 11 1845 1847 (Pubitemid 39434812)
2. World Health Organization U,. UNFPA and the World Bank. Maternal Mortality in 2005: Estimates developed by WHO, UNICEF, UNFPA and the World Bank. 2007
3. Singh S., Wulf D., Hussain R., Bankole A., Sedgh G., Institute G., Abortion Worldwide: A Decade of Uneven Progress 2009 New York, NY, USA Guttmacher Institute
4. UN AIDS World Health Organization,. 09 AIDS Epidemic Update, 2009, http://data.unaids.org/pub/Report/2009/JC1700EpiUpdate2009en.pdf
5. UN AIDS World Health Organization,. 09 AIDS Epidemic Update. Geneva, Switzerland, 2009
6. District of Columbia Department of Health,. 2008, http://dchealth.dc.gov/ doh/frames.asp?doc=/doh/lib/doh/pdf/dchiv-aids2008updatereport.pdf
7. Boily M. C., Baggaley R. F., Wang L., Masse B., White R. G., Hayes R. J., Alary M., Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies The Lancet Infectious Diseases 2009 9 2 118 129
8. Van de Wijgert J. H., Morrison C. S., Brown J., Kwok C., Van Der Pol B., Chipato T., Byamugisha J. K., Obs D., Padian N., Salata R. A., Disentangling contributions of reproductive tract infections to hiv acquisition in African women Sexually Transmitted Diseases 2009 36 6 357 364
9. van de Wijgert J. H., Chirenje Z. M., Iliff V., Mbizvo M. T., Mason P. R., Gwanzura L., Shiboski S., Padian N. S., Effect of intravaginal practices on the vaginal and cervical mucosa of Zimbabwean women Journal of Acquired Immune Deficiency Syndromes 2000 24 1 62 67 (Pubitemid 30447808)
10. Laga M., Manoka A., Kivuvu M., Malele B., Tuliza M., Nzila N., Goeman J., Behets F., Batter V., Alary M., Heyward W. L., Ryder R. W., Piot P., Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study AIDS 1993 7 1 95 102 (Pubitemid 23069039)
11. Van Der Pol B., Kwok C., Pierre-Louis B., Rinaldi A., Salata R. A., Chen P. L., Van De Wijgert J., Mmiro F., Mugerwa R., Chipato T., Morrison C. S., Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women Journal of Infectious Diseases 2008 197 4 548 554 (Pubitemid 351321532)
12. McClelland R. S., Sangare L., Hassan W. M., Lavreys L., Mandaliya K., Kiarie J., Ndinya-Achola J., Jaoko W., Baeten J. M., Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition Journal of Infectious Diseases 2007 195 5 698 702
13. Martin H. L., Richardson B. A., Nyange P. M., Lavreys L., Hillier S. L., Chohan B., Mandaliya K., Ndinya-Achola J. O., Bwayo J., Kreiss J., Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition Journal of Infectious Diseases 1999 180 6 1863 1868
14. Myer L., Kuhn L., Stein Z. A., Wright T. C. Jr., Denny L., Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms The Lancet Infectious Diseases 2005 5 12 786 794 (Pubitemid 41688983)
15. Myer L., Denny L., Telerant R., Souza M., Wright T. C. Jr., Kuhn L., Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study Journal of Infectious Diseases 2005 192 8 1372 1380 (Pubitemid 41401150)
16. Taha T. E., Hoover D. R., Dallabetta G. A., Kumwenda N. I., Mtimavalye L. A. R., Yang L. P., Liomba G. N., Broadhead R. L., Chiphangwi J. D., Miotti P. G., Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV AIDS 1998 12 13 1699 1706 (Pubitemid 28418342)
17. van de Wijgert J. H., Morrison C. S., Cornelisse P. G. A., Munjoma M., Moncada J., Awio P., Wang J., Van Der Pol B., Chipato T., Salata R. A., Padian N. S., Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women Journal of Acquired Immune Deficiency Syndromes 2008 48 2 203 210
18. Lama J. R., Lucchetti A., Suarez L., Laguna-Torres V. A., Guanira J. V., Pun M., Montano S. M., Celum C. L., Carr J. K., Sanchez J., Bautista C. T., Sanchez J. L., Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru Journal of Infectious Diseases 2006 194 10 1459 1466 (Pubitemid 44706516)
19. Rebbapragada A., Wachihi C., Pettengell C., Sunderji S., Huibner S., Jaoko W., Ball B., Fowke K., Mazzulli T., Plummer F. A., Kaul R., Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract AIDS 2007 21 5 589 598
20. Van de Perre P., Segondy M., Foulongne V., Ouedraogo A., Konate I., Huraux J. M., Mayaud P., Nagot N., Herpes simplex virus and HIV-1: deciphering viral synergy The Lancet Infectious Diseases 2008 8 8 490 497 (Pubitemid 352005823)
21. Thurman A. R., Doncel G. F., Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: relationship to HIV acquisition American Journal of Reproductive Immunology 2010 65 2 89 98
22. Gallo M. F., Grimes D. A., Lopez L. M., Schulz K. F., Non-latex versus latex male condoms for contraception Cochrane Database of Systematic Reviews 2006 1
23. Davis K. R., Weller S. C., The effectiveness of condoms in reducing heterosexual transmission of HIV Family Planning Perspectives 1999 31 6 272 279 (Pubitemid 30004240)
24. Mansour D., Inki P., Gemzell-Danielsson K., Efficacy of contraceptive methods: a review of the literature European Journal of Contraception and Reproductive Health Care 2010 15 1 4 16
25. Gollub E. L., Choice is empowering: getting strategic about preventing HIV infection in women International Family Planning Perspectives 2006 32 4 209 212
26. United States Navy. Sexual Health and Responsibility Program. 2010, http://www.nmcphc.med.navy.mil/downloads/sexualhealth/condomaccess.pdf
27. Treerutkuarkul A., Free condoms at gay nightspots The Bangkok Post 2011
28. Trussell J., Sturgen K., Strickler J., Dominik R., Comparative contraceptive efficacy of the female condom and other barrier methods Family Planning Perspectives 1994 26 2 66 72 (Pubitemid 24121722)
29. Farr G., Gabelnick H., Sturgen K., Dorflinger L., Contraceptive efficacy and acceptability of the female condom American Journal of Public Health 1994 84 12 1960 1964
30. French P. P., Latka M., Gollub E. L., Rogers C., Hoover D. R., Stein Z. A., Use-effectiveness of the female versus male condom in preventing sexually transmitted disease in women Sexually Transmitted Diseases 2003 30 5 433 439 (Pubitemid 36605493)
31. Mukandavire Z., Garira W., Sex-structured HIV/AIDS model to analyse the effects of condom use with application to Zimbabwe Journal of Mathematical Biology 2007 54 5 669 699 (Pubitemid 46731520)
32. Dowdy D. W., Sweat M. D., Holtgrave D. R., Country-wide distribution of the nitrile female condom (FC2) in Brazil and South Africa: a cost-effectiveness analysis AIDS 2006 20 16 2091 2098 (Pubitemid 44611062)
33. Warren M., Philpott A., Expanding safer sex options: introducing the female condom into national programmes Reproductive Health Matters 2003 11 21 130 139 (Pubitemid 36687239)
34. Hatcher R. A., Trussell J., Nelson A. L., Cates W., Stewart F. H., Kowal D., Contraceptive Technology 2007 New York, NY, USA Ardent Media
35. World Health Organization, The Safety and Feasibility of Female Condom Reuse: Report of a WHO Consultation 2002 Geneva, Switzerland World Health Organization
36. Coffey P. S., Kilbourne-Brook M., Austin G., Seamans Y., Cohen J., Short-term acceptability of the PATH Woman's condom among couples at three sites Contraception 2006 73 6 588 593
37. Schwartz J. L., Barnhart K., Creinin M. D., Poindexter A., Wheeless A., Kilbourne-Brook M., Mauck C. K., Weiner D. H., Callahan M. M., Comparative crossover study of the PATH Woman's condom and the FC female condom Contraception 2008 78 6 465 473
38. Patterson B. K., Landay A., Andersson J., Brown C., Behbahani H., Jiyamapa D., Burki Z., Stanislawski D., Czerniewski M. A., Garcia P., Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission American Journal of Pathology 1998 153 2 481 490 (Pubitemid 28373659)
39. Li Q., Estes J. D., Schlievert P. M., Duan L., Brosnahan A. J., Southern P. J., Reilly C. S., Peterson M. L., Schultz-Darken N., Brunner K. G., Nephew K. R., Pambuccian S., Lifson J. D., Carlis J. V., Haase A. T., Glycerol monolaurate prevents mucosal SIV transmission Nature 2009 458 7241 1034 1038
40. Moench T. R., Chipato T., Padian N. S., Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices AIDS 2001 15 13 1595 1602 (Pubitemid 32918113)
41. Cook L., Nanda K., Grimes D., Diaphragm versus diaphragm with spermicides for contraception Cochrane Database of Systematic Reviews 2001 2 CD002031
42. Rosenberg M. J., Davidson A. J., Chen J. H., Judson F. N., Douglas J. M., Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms American Journal of Public Health 1992 82 5 669 674
43. Kelaghan J., Rubin G. L., Ory H. W., Layde P. M., Barrier-method contraceptives and pelvic inflammatory disease Journal of the American Medical Association 1982 248 2 184 187 (Pubitemid 12078154)
44. Minnis A. M., Padian N. S., Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions Sexually Transmitted Infections 2005 81 3 193 200 (Pubitemid 40835042)
45. Padian N. S., van der Straten A., Ramjee G., Chipato T., de Bruyn G., Blanchard K., Shiboski S., Montgomery E. T., Fancher H., Cheng H., Rosenblum M., van der Laan M., Jewell N., McIntyre J., Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial The Lancet 2007 370 9583 251 261 (Pubitemid 47069513)
46. Ramjee G., van der Straten A., Chipato T., de Bruyn G., Blanchard K., Shiboski S., Cheng H., Montgomery E., Padian N., The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial PLoS One 2008 3 10
47. Schwartz J. L., Ballagh S. A., Creinin M. D., Rountree R. W., Kilbourne-Brook M., Mauck C. K., Callahan M. M., SILCS diaphragm: postcoital testing of a new single-size contraceptive device Contraception 2008 78 3 237 244
48. Coffey P. S., Kilbourne-Brook M., Brache V., Cochon L., Comparative acceptability of the SILCS and Ortho ALL-FLEX diaphragms among couples in the Dominican Republic Contraception 2008 78 5 418 423
49. Malkovsky M., Newell A., Dalgleish A. G., Inactivation of HIV by nonoxynol-9 The Lancet 1988 1 8586 645 (Pubitemid 18083248)
50. Polsky B., Baron P. A., Gold J. W., Smith J. L., Jensen R. H., Armstrong D., In vitro inactivation of HIV-1 by contraceptive sponge containing nonoxynol-9 The Lancet 1988 1 8600 1456
51. Harrison C., Chantler E., The effect of nonoxynol-9 and chlorhexidine on HIV and sperm in vitro International Journal of STD and AIDS 1998 9 2 92 97 (Pubitemid 28083631)
52. Hicks D. R., Martin L. S., Getchell J. P., Heath J. L., Francis D. P., McDougal J. S., Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro The Lancet 1985 2 8469-8470 1422 1423 (Pubitemid 16138571)
53. Jennings R., Clegg A., The inhibitory effect of spermicidal agents on replication of HSV-2 and HIV-1 in-vitro Journal of Antimicrobial Chemotherapy 1993 32 1 71 82 (Pubitemid 23247591)
54. Feldblum P. J., Adeiga A., Bakare R., Wevill S., Lendvay A., Obadaki F., Olayemi M. O., Wang L., Nanda K., Roundtree W., SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria PLoS One 2008 3 1
55. Van Damme L., Ramjee G., Alary M., Vuylsteke B., Chandeying V., Rees H., Sirivongrangson P., Mukenge-Tshibaka L., Uaheowitchai C., Abdool Karim S. S., Laga M., Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial The Lancet 2002 360 9338 971 977 (Pubitemid 35284107)
56. Peterson L., Nanda K., Opoku B. K., Ampofo W. K., Owusu-Amoaka M., Boakye A. Y., Rountree W., Troxler A., Dominik R., Roddy R., Dorflinger L., SAVVY (C31G) gel for prevention of HIV infection in women: a phase 3, double-blind, randomized, placebo-controlled trial in Ghana PLoS One 2007 2 12, article e1312
57. Mauck C. K., Freziers R. G., Walsh T. L., Peacock K., Schwartz J. L., Callahan M. M., Noncomparative contraceptive efficacy of cellulose sulfate gel Obstetrics and Gynecology 2008 111 3 739 746 (Pubitemid 351654081)
58. Halpern V., Ogunsola F., Obunge O., Wang C. H., Onyejepu N., Oduyebo O., Taylor D., McNeil L., Mehta N., Umo-Otong J., Otusanya S., Crucitti T., Abdellati S., Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a phase III trial in Nigeria PLoS One 2008 3 11, article e3784
59. Skoler-Karpoff S., Ramjee G., Ahmed K., Altini L., Plagianos M. G., Friedland B., Govender S., De Kock A., Cassim N., Palanee T., Dozier G., Maguire R., Lahteenmaki P., Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial The Lancet 2008 372 9654 1977 1987
60. McCormack S., Ramjee G., Kamali A., Rees H., Crook A. M., Gafos M., Jentsch U., Pool R., Chisembele M., Kapiga S., Mutemwa R., Vallely A., Palanee T., Sookrajh Y., Lacey C. J., Darbyshire J., Grosskurth H., Profy A., Nunn A., Hayes R., Weber J., PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial The Lancet 2010 376 9749 1329 1337
61. Van Damme L., Govinden R., Mirembe F. M., Guedou F., Solomon S., Becker M. L., Pradeep B. S., Krishnan A. K., Alary M., Pande B., Ramjee G., Deese J., Crucitti T., Taylor D., Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission The New England Journal of Medicine 2008 359 5 463 472
62. Abdool Karim S. S., Richardson B. A., Ramjee G., Hoffman I. F., Chirenje Z. M., Taha T., Kapina M., Maslankowski L., Coletti A., Profy A., Moench T. R., Piwowar-Manning E., Msse B., Hillier S. L., Soto-Torres L., Safety and effectiveness of BufferGel and 0.5 PRO2000 gel for the prevention of HIV infection in women AIDS 2011 25 7 957 966
63. Olmsted S. S., Dubin N. H., Cone R. A., Moench T. R., The rate at which human sperm are immobilized and killed by mild acidity Fertility and Sterility 2000 73 4 687 693 (Pubitemid 30154104)
64. Burke A. E., Barnhart K., Jensen J. T., Contraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: a randomized controlled trial Obstetrics Gynecology 2010 116 6 1265 1273
65. Moench T., Baker J., Cone R., BufferGel is an Active Spermicide in the Standardized Postcoital Test 2000 Alexandria, VA, USA Microbicides
66. Garg S., Anderson R. A., Chany C. J. II, Waller D. P., Xia Hui Diao, Vermani K., Zaneveld L. J. D., Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM) Contraception 2001 64 1 67 75 (Pubitemid 32787100)
67. Amaral E., Perdigao A., Souza M. H., Mauck C., Waller D., Zaneveld L., Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2 nonoxynol-9 product Contraception 2004 70 6 492 497 (Pubitemid 39488207)
68. Hughes L. M., Griffith R., Aitken R. J., The search for a topical dual action spermicide/microbicide Current Medicinal Chemistry 2007 14 7 775 786 (Pubitemid 46477711)
69. Zairi A., Belaid A., Gahbiche A., Hani K., Spermicidal activity of dermaseptins Contraception 2005 72 6 447 453 (Pubitemid 41676836)
70. Belaid A., Aouni M., Khelifa R., Trabelsi A., Jemmali M., Hani K., In vitro antiviral activity of dermaseptins against herpes simplex virus type 1 Journal of Medical Virology 2002 66 2 229 234 (Pubitemid 34020073)
71. Reddy K. V. R., Shahani S. K., Meherji P. K., Spermicidal activity of magainins: in vitro and in vivo studies Contraception 1996 53 4 205 210 (Pubitemid 26118148)
72. D'Cruz O. J., Uckun F. M., Dawn of non-nucleoside inhibitor-based anti-HIV microbicides Journal of Antimicrobial Chemotherapy 2006 57 3 411 423 (Pubitemid 43240192)
73. Agarwal H. K., Kumar A., Doncel G. F., Parang K., Synthesis, antiviral and contraceptive activities of nucleoside-sodium cellulose sulfate acetate and succinate conjugates Bioorganic and Medicinal Chemistry Letters 2010 20 23 6993 6997
74. Karim Q. A., Karim S. S. A., Frohlich J. A., Grobler A. C., Baxter C., Mansoor L. E., Kharsany A. B. M., Sibeko S., Mlisana K. P., Omar Z., Gengiah T. N., Maarschalk S., Arulappan N., Mlotshwa M., Morris L., Taylor D., Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women Science Express 2010 329 5996 1168 1174
75. Weiss H., Epidemiology of herpes simplex virus type 2 infection in the developing world Herpes 2004 11 supplement 1 24A 35A (Pubitemid 38529332)
76. John M., Keller M. J., Fam E. H., Cheshenko N., Hogarty K., Kosowitz A., Wallenstein S., Carlucci M. J., Tuyama A. C., Lu W., Klotman M. E., Lehrer R. I., Herold B. C., Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection Journal of Infectious Diseases 2005 192 10 1731 1740 (Pubitemid 41587823)
77. Freeman E. E., Weiss H. A., Glynn J. R., Cross P. L., Whitworth J. A., Hayes R. J., Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies AIDS 2006 20 1 73 83 (Pubitemid 41818117)
78. Wald A., Link K., Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis Journal of Infectious Diseases 2002 185 1 45 52 (Pubitemid 34043015)
79. Watson-Jones D., Weiss H. A., Rusizoka M., Changalucha J., Baisley K., Mugeye K., Tanton C., Ross D., Everett D., Clayton T., Balira R., Knight L., Hambleton I., Le Goff J., Belec L., Hayes R., Nunn A., Cowan F., Kapiga S., Mshinda H., Dunn D., Grosskurth H., Kilama W., Effect of herpes simplex suppression on incidence of HIV among women in Tanzania The New England Journal of Medicine 2008 358 15 1560 1571 (Pubitemid 351519816)
80. Celum C., Wald A., Hughes J., Sanchez J., Reid S., Delany-Moretlwe S., Cowan F., Casapia M., Ortiz A., Fuchs J., Buchbinder S., Koblin B., Zwerski S., Rose S., Wang J., Corey L., Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial The Lancet 2008 371 9630 2109 2119 (Pubitemid 351902179)
81. Celum C., Wald A., Lingappa J. R., Magaret A. S., Wang R. S., Mugo N., Mujugira A., Baeten J. M., Mullins J. I., Hughes J. P., Bukusi E. A., Cohen C. R., Katabira E., Ronald A., Kiarie J., Farquhar C., Stewart G. J., Makhema J., Essex M., Were E., Fife K. H., De Bruyn G., Gray G. E., McIntyre J. A., Manongi R., Kapiga S., Coetzee D., Allen S., Inambao M., Kayitenkore K., Karita E., Kanweka W., Delany S., Rees H., Vwalika B., Stevens W., Campbell M. S., Thomas K. K., Coombs R. W., Morrow R., Whittington W. L. H., McElrath M. J., Barnes L., Ridzon R., Corey L., Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2 The New England Journal of Medicine 2010 362 5 427 439
82. Zhu J., Hladik F., Woodward A., Klock A., Peng T., Johnston C., Remington M., Magaret A., Koelle D. M., Wald A., Corey L., Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition Nature Medicine 2009 15 8 886 892
83. Zhu J., Koelle D. M., Cao J., Vazquez J., Meei L. H., Hladik F., Wald A., Corey L., Virus-specific CD8 + T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation Journal of Experimental Medicine 2007 204 3 595 603 (Pubitemid 46457082)
84. Feigin R. D., Cherry J. D., Textbook of Pediatric Infectious Diseases 1998 Sydney, Australia Elsevier
85. Van Dyke R. B., Connor J. D., Wyborny C., Hintz M., Keeney R. E., Pharmacokinetics of orally administered acyclovir in patients with herpes progenitalis American Journal of Medicine 1982 73 1 A 172 175 (Pubitemid 12067779)
86. Gupta R., Hill E. L., McClernon D., Davis G., Selke S., Corey L., Wald A., Acyclovir sensitivity of sequential herpes simplex virus type 2 isolates from the genital mucosa of immunocompetent women Journal of Infectious Diseases 2005 192 6 1102 1107 (Pubitemid 41266810)
87. Kashuba A. D. M., Karim S. S. A., Kraft E., White N., Sibeko S., Werner L., Do Systemic and Genital tract Tenofovir Concentrations Predict HIV Seroconversion in the CAPRISA 004 Tenofovir Gel Trial? 2010 Vienna, Austria AIDS
88. Buck C. B., Thompson C. D., Roberts J. N., Muller M., Lowy D. R., Schiller J. T., Carrageenan is a potent inhibitor of papillomavirus infection PLoS Pathogens 2006 2 7, article e69
89. Kenney J., Aravantinou M., Singer R., Antiretroviral/zinc combination gel provides 24hours of complete protection against vaginal SHIV infection in macaques PLoS One 2011 6 1 e15835
90. Haraguchi Y., Sakurai H., Hussain S., Anner B. M., Hoshino H., Inhibition of HIV-1 infection by zinc group metal compounds Antiviral Research 1999 43 2 123 133 (Pubitemid 29415659)
91. Kumel G., Schrader S., Zentgraf H., Daus H., Brendel M., The mechanism of the antiherpetic activity of zinc sulphate Journal of General Virology 1990 71, part 12 2989 2997
92. Arens M., Travis S., Zinc salts inactivate clinical isolates of herpes simplex virus in vitro Journal of Clinical Microbiology 2000 38 5 1758 1762 (Pubitemid 30253910)
93. Burton F. G., Skiens W. E., Duncan G. W., Low-level, progestogen- releasing vaginal contraceptive devices Contraception 1979 19 5 507 516 (Pubitemid 9174402)
94. Xiao B. L., Zhang X. L., Feng D. D., Pharmacokinetic and pharmacodynamic studies of vaginal rings releasing low-dose levonorgestrel Contraception 1985 32 5 455 471
95. Koetsawang S., Ji G., Krishna U., Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. world health organization. Task force on long-acting systemic agents for fertility regulation Contraception 1990 41 2 105 124
96. Koetsawang S., Ji G., Krishna U., Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. IV. Bleeding patterns. world health organization. Task force on long-acting systemic agents for fertility regulation Contraception 1990 41 2 151 167 (Pubitemid 20060856)
97. Koetsawang S., Ji G., Krishna U., Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. II. Expulsions and removals. world health organization. Task force on long-acting systemic agents for fertility regulation Contraception 1990 41 2 125 141 (Pubitemid 20060854)
98. Johnson T. J., Gupta K. M., Fabian J., Albright T. H., Kiser P. F., Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir European Journal of Pharmaceutical Sciences 2010 39 4 203 212
99. Nel A., Smythe S., Young K., Malcolm K., McCoy C., Rosenberg Z., Romano J., Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women Journal of Acquired Immune Deficiency Syndromes 2009 51 4 416 423
100. Romano J., Variano B., Coplan P., Van Roey J., Douville K., Rosenberg Z., Temmerman M., Verstraelen H., Van Bortel L., Weyers S., Mitchnick M., Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring AIDS Research and Human Retroviruses 2009 25 5 483 488
101. Gupta K. M., Pearce S. M., Poursaid A. E., Aliyar H. A., Tresco P. A., Mitchnik M. A., Kiser P. F., Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1 Journal of Pharmaceutical Sciences 2008 97 10 4228 4239
102. Fletcher P., Harman S., Azijn H., Armanasco N., Manlow P., Perumal D., De Bethune M. P., Nuttall J., Romano J., Shattock R., Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor Antimicrobial Agents and Chemotherapy 2009 53 2 487 495
103. Nel A. M., Coplan P., Smythe S. C., McCord K., Mitchnick M., Kaptur P. E., Romano J., Pharmacokinetic assessment of dapivirine vaginal microbicide gel in healthy, HIV-negative women AIDS Research and Human Retroviruses 2010 26 11 1181 1190
104. Nel A. M., Smythe S. C., Habibi S., Kaptur P. E., Romano J. W., Pharmacokinetics of 2 dapivirine vaginal microbicide gels and their safety Vs. Hydroxyethyl cellulose-based universal placebo gel Journal of Acquired Immune Deficiency Syndromes 2010 55 2 161 169
105. Coalition Advancing Multipurpose Innovations (CAMI), CAMI.org. Microbicides and Devices Matrix, 2011
106. Thurman A. R., Holden A. E. C., Shain R. N., Perdue S., Piper J. M., Effect of acculturation on the acceptability of potential microbicides and sexual risk-taking Sexually Transmitted Diseases 2009 36 6 387 394